Uthman et al recently proved that SGLT2 inhibitors played a direct role in combating heart failure by inhibiting myocardial mitochondrial Na+/H+ exchanger flux and subsequently reducing intracellular free Na+, which was consistent with Durak and coworkers’ findings.49, 50. This evidence concerns the gene SLC5A2 and heart failure.